CLINICAL_TRIALS
trial_result
· 2015-11-27
Clinical Trial Update: To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer [Phase 4]
Summary
A Phase 4 trial comparing two doses of vandetanib in patients with advanced medullary thyroid carcinoma has completed. Results were posted on 2015-11-27.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Thyroid Cancer | Phase 4 | Status: COMPLETED | Results posted: 2015-11-27